As a result of the government’s reimbursement reevaluations, patients will be unable to receive reimbursement when using hyaluronic acid eye drops for extrinsic diseases, and the amount of their use will also be restricted.

The government has also been known to be discussing limiting reimbursement to 4 boxes per year.

According to industry sources on the 5th, the Health Insurance Review and Assessment Service is said to have set such a direction regarding the reimbursement of HA eye drops after conducting reevaluations on the adequacy of their reimbursement this year.

HA eye drops, rebamipide, limaprost oxiracetam, loxoprofen sodium, levosulpiride, and epinastine hydrochl